Weiss Multi-Strategy Advisers’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,390
Closed -$305K 758
2023
Q2
$305K Buy
+9,390
New +$343K 0.01% 595
2022
Q1
Sell
-9,040
Closed -$385K 817
2021
Q4
$385K Sell
9,040
-960
-10% -$48K 0.01% 569
2021
Q3
$550K Sell
10,000
-144
-1% -$7.54K 0.01% 543
2021
Q2
$485K Buy
10,144
+1,128
+13% +$57.5K 0.01% 553
2021
Q1
$457K Sell
9,016
-8,315
-48% -$462K 0.01% 551
2020
Q4
$1.09M Sell
17,331
-2,708
-14% -$168K 0.02% 479
2020
Q3
$1.35M Buy
20,039
+7,488
+60% +$409K 0.04% 396
2020
Q2
$526K Sell
12,551
-1,281
-9% -$49.2K 0.02% 463
2020
Q1
$435K Buy
13,832
+3,832
+38% +$153K 0.02% 352
2019
Q4
$404K Hold
10,000
0.01% 544
2019
Q3
$325K Buy
+10,000
New +$398K 0.01% 518

Other funds holding SILK

Weiss Multi-Strategy Advisers's SILK Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2023, closing a stake of 9,390 shares — an estimated $305K sold.

Weiss Multi-Strategy Advisers first reported a position in SILK in Q3 2019 and held it in 11 quarters. The position peaked at $1.35M in Q3 2020. 166 funds tracked by Wall St. Rank hold SILK as of Q3 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 9,390 Silk Road Medical, Inc. Common Stock shares in Q3 2023, an estimated $305K.
  • Weiss Multi-Strategy Advisers first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2019 and held it in 11 quarters.
  • Weiss Multi-Strategy Advisers's Silk Road Medical, Inc. Common Stock position peaked at $1.35M in Q3 2020.
  • 166 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.